LY-02404
- Generic Name
- LY-02404
The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 398
- Registration Number
- NCT06750783
- Locations
- 🇨🇳
Beiqijia Community Health Service Center, Changping District, Beijing, Beijing, Beijing, China
🇨🇳Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
🇨🇳Xiaotangshan Community Health Service Center, Changping District, Beijing, Beijing, Beijing, China
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Luye Pharma Group Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02603770
- Locations
- 🇺🇸
NRC Research Institute, Orange, California, United States
Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients
Phase 4
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02254824
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, Beijing, China
The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin
- First Posted Date
- 2012-09-18
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Wenzhou Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT01686451
- Locations
- 🇨🇳
Second Hispital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath